enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Why VIVUS Lost in November - AOL

   www.aol.com/news/2012-12-04-why-vivus-lost-in...

   VIVUS' (NAS: VVUS) stock was down 25% for November, though still up 15% for the year. Its drug Qsymia is the first obesity drug to be approved and reach the market in more than a decade, but its ...

3. Does The VIVUS, Inc. (NASDAQ:VVUS) Share Price Fall ... - AOL

   www.aol.com/news/does-vivus-inc-nasdaq-vvus...

   For premium support please call: 800-290-4726 more ways to reach us

4. Down 20%: What Is VIVUS' Market Opportunity? - AOL

   www.aol.com/2012/11/06/down-20-what-is-vivus...

   VIVUS (NAS: VVUS) may have beaten its rival Arena Pharmaceuticals (NAS: ARNA) in getting an obesity drug on the market first, but its shares plunged almost 20% this morning after reporting ...

5. VVUS: New Ideas for Established Portfolio

   www.aol.com/news/vvus-ideas-established...

   We are initiating coverage of VIVUS, Inc. (VVUS) with a $10.00 price target based on our revenue forecasts for approved products. In addition to a portfolio of weight loss, exocrine pancreatic ...

6. Buy, Sell, or Hold: VIVUS

   www.aol.com/2012/06/12/buy-sell-or-hold-vivus

   For premium support please call: 800-290-4726 more ways to reach us

7. Why VIVUS Shares Soared - AOL

   www.aol.com/news/2012-10-08-why-vivus-shares...

   For premium support please call: 800-290-4726 more ways to reach us

8. Is a VIVUS Buyout Still on the Table? And if So, by Whom? - AOL

   www.aol.com/news/2012-10-12-is-a-vivus-buyout...

   For premium support please call: 800-290-4726 more ways to reach us

9. VIVUS Seeks to Expand Market Reach - AOL

   www.aol.com/2012/10/18/vivus-seeks-to-expand...

   A week after signing up Express Scripts (NAS: ESRX) to sell Qsymia, VIVUS (NAS: VVUS) is looking to expand its market reach even further. The obesity drug is currently only available through mail ...